UNSPSC 51182035: Nilutamide

This classification denotes an anti-androgen with the molecular formula C12H10F3N3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 51G6I8B902, chemically known as 5,5-dimethyl-3-(alpha,alpha,alpha-trifluoro-4-nitro-m-tolyl)hydantoin but generally known as nilutamide, which bears US NIH Compound Identifier 4493. European Medicines Agency schedules Nilutamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09291MIG.

UNSPSC 51182035 Nilutamide is a Commodity code for a specific pharmaceutical active ingredient used in prostate cancer treatment, yet the source provides no recent state and local procurement opportunities under this code. Without access to posted solicitations, I cannot characterize the kinds of issuing bodies procuring nilutamide, the geographic distribution of demand, or representative recent opportunities. Nilutamide procurement at the state and local level typically occurs through hospital pharmacy systems, state Medicaid programs, and county health departments as part of broader oncology drug formularies or GPO cooperative purchasing agreements, but this summary cannot confirm current activity, volume, or buyer concentration based on the source material provided.

The code shows no substantive recent procurement signal in the state and local market. Business development professionals evaluating this code should verify current demand directly with state Medicaid agencies, hospital systems, and group purchasing organizations rather than rely on posted open solicitations.